Michael Gelband’s ArcBest ARCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Sell
11,017
-36,498
-77% -$4.75M 0.01% 918
2026
Q1
$4.67M Buy
+47,515
New +$4.5M 0.04% 460
2024
Q3
Sell
-34,934
Closed -$3.74M 1603
2024
Q2
$3.74M Buy
+34,934
New +$4.21M 0.03% 526
2024
Q1
Sell
-121,915
Closed -$14.7M 1473
2023
Q4
$14.7M Buy
121,915
+24,914
+26% +$2.76M 0.1% 148
2023
Q3
$9.86M Buy
97,001
+41,075
+73% +$4.31M 0.09% 229
2023
Q2
$5.53M Buy
55,926
+51,586
+1,189% +$4.61M 0.04% 417
2023
Q1
$401K Buy
+4,340
New +$390K ﹤0.01% 1395
2022
Q3
Sell
-20,536
Closed -$1.45M 1855
2022
Q2
$1.45M Buy
20,536
+5,887
+40% +$433K 0.02% 923
2022
Q1
$1.18M Buy
+14,649
New +$1.32M 0.01% 1056
2021
Q3
Sell
-19,458
Closed -$1.13M 2085
2021
Q2
$1.13M Buy
+19,458
New +$1.39M 0.01% 945
2020
Q1
Sell
-18,900
Closed -$522K 1067
2019
Q4
$522K Buy
+18,900
New +$546K 0.01% 830

Other funds holding ARCB

Michael Gelband's ARCB Position: Q2 2026 in Review

Michael Gelband reduced its ArcBest (ARCB) stake by 77% in Q2 2026, selling an estimated $4.75M and leaving 11,017 shares worth $1.58M. The position accounts for 0.01% of the portfolio, ranked #918.

Michael Gelband first reported a position in ARCB in Q4 2019 and has held it in 11 quarters since. The position peaked at $14.7M in Q4 2023. 328 funds tracked by Wall St. Rank hold ARCB as of Q2 2026.

  • Michael Gelband held 11,017 shares of ArcBest worth $1.58M as of Q2 2026.
  • Michael Gelband sold 36,498 ArcBest shares in Q2 2026, an estimated $4.75M.
  • ArcBest made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #918 holding.
  • Michael Gelband first reported a position in ArcBest in Q4 2019 and has held it in 11 quarters since.
  • Michael Gelband's ArcBest position peaked at $14.7M in Q4 2023.
  • 328 funds tracked by Wall St. Rank held ArcBest as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.